Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sanjay Patel
Institutions:
Cornell University,
Weill Cornell Medicine,
OU Health Stephenson Cancer Center,
University of Oklahoma Health Sciences Center,
Rush University
Observed institutions:
Cornell University,
Weill Cornell Medicine,
OU Health Stephenson Cancer Center,
University of Oklahoma Health Sciences Center,
Rush University
OpenAlex ID:
A5127784591
Circulating tumor DNA response adapted treatment de-escalation in metastatic urothelial carcinoma (CT-READ).
2026
·
Abdul Qadar
, Syed Saqib Balkhi
, et al.
·
Journal of Clinical Oncology
·
1
Supplemental Material For : A unique case of thymic indolent T-lymphoblastic proliferation: Redefining the extrathymic boundaries
2026
·
figshare admin karger
, Chandler B. Sy
, et al.
·
Figshare
22 Phase II Study of Cemiplimab ± Fianlimab Following SBRT for Oligometastatic Clear-Cell RCC (LAG-BOOST) (NCT07223541)
2026
·
Abhirami Das
, Syed Balkhi
, et al.
·
The Oncologist
PDF
79 Renal Cell Carcinoma Among Native American Patients in Oklahoma: A Single-Institution Experience from an NCI-Designated Cancer Center
2026
·
Jafer Raza
, Anoushka Mullasseril
, et al.
·
The Oncologist
PDF
Extraction of atrial tumor thrombus in renal cell carcinoma via a complete transabdominal approach
2026
·
Kaitlin Pardue
, E. Joy Trimble
, et al.
·
Translational Andrology and Urology
Kikuchi-Fujimoto Disease as an Etiology for Relapsing/Remitting Fevers and Lymphadenopathy in a Patient With Dermatomyositis
2026
·
Danny Luan
, Kavya Penmethsa
, et al.
·
Annals of Internal Medicine Clinical Cases
Phase II study of cemiplimab ± fianlimab following SBRT for oligometastatic clear-cell RCC (LAG-BOOST).
2026
·
Abhirami Das
, Syed Saqib Balkhi
, et al.
·
Journal of Clinical Oncology
Genomic and transcriptomic correlates of HER3 expression in prostate cancer.
2026
·
Syed Saqib Balkhi
, Anoushka Mullasseril
, et al.
·
Journal of Clinical Oncology
Abstract LB427: Humanized PDX models uncover drug-reversible epigenetic immune exclusion governing T-cell therapy response in DLBCL, captured in patients by EPICORE stratifier
2026
·
Giovanni Medico
, Giorgia Zanetti
, et al.
·
Cancer Research
Rewiring BCL6 with Transcriptional/epigenetic Chemical Inducers of Proximity Unveils Targetable Plasticity in Large B Cell Lymphoma
2026
·
Haopeng Yang
, Kevin Bowman
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
10
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type